Publications
Nguyen J, Mitratza M, Volkman HR, de Munter L, Tran TMP, Marques C, Mustapha M, Valluri S, Yang J, Antón A, Casas I, Conde-Sousa E, Drikite L, Grüner B, Icardi G, Luit ten Kate G, Martin C, Mira-Iglesias A, Orrico- Sánchez A, Otero-Romero S, Rohde G , Stolz D , Jodar L, M McLaughlin J, Bollaerts K. Effectiveness of the BNT162b2 XBB.1.5-adapted vaccine against COVID-19 hospitalization related to the JN.1 variant in Europe: A test-negative case-control study using the id.DRIVE platform.
Lancet Infectious Diseases (2024)
Preprint available at: http://dx.doi.org/10.2139/ssrn.4859538
Wilhelmine Meeraus, Leonie de Munter, Christen M. Gray, Akshat Dwivedi, Chloé Wyndham-Thomas, Mario Ouwens, Wendy Hartig-Merkel, Laura Drikite, Griet Rebry, Antonio Carmona, Anke L. Stuurman, Thi Yen Chi Nguyen, Guillermo Mena, Ainara Mira-Iglesias, Giancarlo Icardi, Susana Otero-Romero, Sebastian Baumgartner, Charlotte Martin, Sylvia Taylor, and Kaatje Bollaerts. Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis.
The Lancet Regional Health – Europe (2023),
https://doi.org/10.1016/j.lanepe.2023.100675